• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 SEER 数据库的回顾性研究:开发和验证用于巨块型肝细胞癌(≥10cm)的基于网络的预后列线图。

Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.

机构信息

Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China.

出版信息

Cancer Med. 2023 Jun;12(12):13167-13181. doi: 10.1002/cam4.6003. Epub 2023 Apr 27.

DOI:10.1002/cam4.6003
PMID:37102245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10315854/
Abstract

BACKGROUND AND AIMS

Massive hepatocellular carcinoma (MHCC, a maximum tumor size of at least 10 cm) tends to have a poor prognosis. Therefore, this study aims to construct and validate prognostic nomograms for MHCC.

METHODS

Clinic data of 1292 MHCC patients between 2010 and 2015 were got from the surveillance, epidemiology, and end results (SEER) cancer registration database. The whole set was separated into the training and validation sets at a ratio of 2:1 randomly. Variables, significantly associated with cancer-specific (CSS) and overall survival (OS) of MHCC were figured out by multivariate Cox regression analysis and were taken to develop nomograms. The concordance index (C-index), calibration curve, and decision curve analysis (DCA) were taken to validate the predictive abilities and accuracy of the nomograms.

RESULTS

Race, alpha-fetoprotein (AFP), grade, combined summary stage, and surgery were identified as independent factors of CSS, and fibrosis score, AFP, grade, combined summary stage, and surgery significantly correlated with OS in the training cohort. They then were taken to construct prognostic nomograms. The constructed model for predicting CSS exhibited satisfactory performance with a C-index of 0.727 (95% CI: 0.746-0.708) in the training group and 0. 672 (95% CI: 0.703-0.641) in the validation group. Besides, the model for predicting OS of MHCC also showed strong performance both in the training group (C-index: 0.722, 95% CI: 0.741-0.704) and the validation (C-index: 0.667, 95% CI: 0.696-0.638) group. All calibration curves and decision curves performed satisfactory predictive accuracy and clinic application values of the nomograms.

CONCLUSION

The web-based nomograms for CSS and OS of MHCC were developed and validated in this study, which prospectively could be tested and may serve as additional tools to assess patient's individualized prognosis and make precise therapeutic selection to improve the poor outcome of MHCC.

摘要

背景与目的

巨块型肝癌(MHCC,肿瘤最大径至少为 10cm)往往预后不良。因此,本研究旨在构建和验证 MHCC 的预后列线图。

方法

从监测、流行病学和最终结果(SEER)癌症登记数据库中获取 2010 年至 2015 年间 1292 例 MHCC 患者的临床数据。将整个数据集按 2:1 的比例随机分为训练集和验证集。通过多变量 Cox 回归分析确定与 MHCC 患者癌症特异性生存(CSS)和总生存(OS)显著相关的变量,并用于开发列线图。采用一致性指数(C-index)、校准曲线和决策曲线分析(DCA)来验证列线图的预测能力和准确性。

结果

种族、甲胎蛋白(AFP)、分级、综合分期和手术被确定为 CSS 的独立因素,纤维化评分、AFP、分级、综合分期和手术与训练队列中的 OS 显著相关。然后,它们被用来构建预后列线图。用于预测 CSS 的模型在训练组中的 C-index 为 0.727(95%CI:0.746-0.708),在验证组中的 C-index 为 0.672(95%CI:0.703-0.641),表现出良好的性能。此外,用于预测 MHCC OS 的模型在训练组(C-index:0.722,95%CI:0.741-0.704)和验证组(C-index:0.667,95%CI:0.696-0.638)中均表现出较强的性能。所有校准曲线和决策曲线均表现出良好的预测准确性和列线图的临床应用价值。

结论

本研究构建并验证了基于网络的 MHCC CSS 和 OS 列线图,可对其进行前瞻性测试,并可能作为评估患者个体化预后的附加工具,以及进行精准治疗选择,从而改善 MHCC 的不良预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/7e77733ef5c4/CAM4-12-13167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/abe7056427ed/CAM4-12-13167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/ff218e4182f9/CAM4-12-13167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/8c1d3ca6372a/CAM4-12-13167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/7e77733ef5c4/CAM4-12-13167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/abe7056427ed/CAM4-12-13167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/ff218e4182f9/CAM4-12-13167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/8c1d3ca6372a/CAM4-12-13167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a299/10315854/7e77733ef5c4/CAM4-12-13167-g002.jpg

相似文献

1
Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.基于 SEER 数据库的回顾性研究:开发和验证用于巨块型肝细胞癌(≥10cm)的基于网络的预后列线图。
Cancer Med. 2023 Jun;12(12):13167-13181. doi: 10.1002/cam4.6003. Epub 2023 Apr 27.
2
Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.开发和评估列线图和风险分层系统,以预测肝细胞癌患者的总生存率和癌症特异性生存率。
Clin Exp Med. 2024 Feb 28;24(1):44. doi: 10.1007/s10238-024-01296-1.
3
Construction of webbased prediction nomogram models for cancerspecific survival in patients at stage IV of hepatocellular carcinoma depending on SEER database.基于监测、流行病学和最终结果(SEER)数据库构建用于预测肝细胞癌IV期患者癌症特异性生存的网络预测列线图模型。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1546-1560. doi: 10.11817/j.issn.1672-7347.2023.230040.
4
Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.构建并验证基于 SEER 数据库的多中心肝细胞癌患者列线图模型。
Eur J Surg Oncol. 2023 Oct;49(10):106966. doi: 10.1016/j.ejso.2023.06.018. Epub 2023 Jun 21.
5
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.基于 SEER 数据库的老年早期肝细胞癌患者癌症特异性生存的网络预测模型研究。
Front Public Health. 2022 Jan 13;9:789026. doi: 10.3389/fpubh.2021.789026. eCollection 2021.
6
Construction and validation of a nomogram for predicting cancer-specific survival in middle-aged patients with advanced hepatocellular carcinoma: A SEER-based study.构建并验证基于 SEER 数据库的用于预测中年晚期肝细胞癌患者癌症特异性生存的列线图
Medicine (Baltimore). 2024 Sep 20;103(38):e39480. doi: 10.1097/MD.0000000000039480.
7
A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.基于 LASSO Cox 回归的 AFP 阴性肝癌患者非手术治疗后预后列线图。
BMC Cancer. 2021 Mar 8;21(1):246. doi: 10.1186/s12885-021-07916-3.
8
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.基于 SEER 数据库的人群研究:用于预测老年早期肺癌患者总生存和癌症特异生存的列线图。
Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022.
9
Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.成人原发性高级别胶质瘤患者预后列线图:基于 SEER 数据库的回顾性研究。
Biomed Res Int. 2020 Jul 23;2020:1346340. doi: 10.1155/2020/1346340. eCollection 2020.
10
Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.用于预测非转移性鼻咽癌生存结局并指导治疗的两个基于网络的动态交互式列线图和风险分层系统。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15969-15987. doi: 10.1007/s00432-023-05363-0. Epub 2023 Sep 8.

引用本文的文献

1
Effect of surgery on overall survival and cancer-specific survival in patients with primary HCC: A study based on PSM in the SEER cohort.手术对原发性肝癌患者总生存和癌症特异性生存的影响:一项基于监测、流行病学和最终结果(SEER)队列倾向评分匹配法的研究
Medicine (Baltimore). 2025 Feb 21;104(8):e41521. doi: 10.1097/MD.0000000000041521.
2
The continuous improvement of digital assistance in the radiation oncologist's work: from web-based nomograms to the adoption of large-language models (LLMs). A systematic review by the young group of the Italian association of radiotherapy and clinical oncology (AIRO).放射肿瘤学家工作中数字辅助的持续改进:从基于网络的列线图到大型语言模型(LLMs)的应用。意大利放射治疗与临床肿瘤学协会(AIRO)青年小组的系统评价
Radiol Med. 2024 Nov;129(11):1720-1735. doi: 10.1007/s11547-024-01891-y. Epub 2024 Oct 13.

本文引用的文献

1
Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan.基于白蛋白-胆红素分级的新型新格拉斯哥预后评分与目前用于肝细胞癌手术切除后预后预测的营养指标的比较:日本的一项多中心回顾性研究
Cancers (Basel). 2022 Apr 22;14(9):2091. doi: 10.3390/cancers14092091.
2
Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.经导管动脉化疗栓塞联合仑伐替尼加 PD-1 抑制剂治疗晚期肝细胞癌:一项回顾性队列研究。
Front Immunol. 2022 Mar 1;13:848387. doi: 10.3389/fimmu.2022.848387. eCollection 2022.
3
A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma.一种用于预测年轻肝细胞癌患者手术后预后的列线图。
Transl Cancer Res. 2021 Apr;10(4):1773-1786. doi: 10.21037/tcr-20-3411.
4
CT radiomics nomogram for the preoperative prediction of severe post-hepatectomy liver failure in patients with huge (≥ 10 cm) hepatocellular carcinoma.基于 CT 影像组学的nomogram 模型预测直径≥10cm 肝细胞癌患者术后发生重度肝衰竭的风险
World J Surg Oncol. 2021 Dec 12;19(1):344. doi: 10.1186/s12957-021-02459-0.
5
Report of the 18th follow-up survey of primary liver cancer in Japan.日本原发性肝癌第18次随访调查报告。
Hepatol Res. 2010 Nov;40(11):1043-1059. doi: 10.1111/j.1872-034X.2010.00731.x.
6
Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy.肿瘤大小可能会影响无大血管侵犯肝硬化单发肝细胞癌患者术后的预后。
Sci Rep. 2021 Aug 11;11(1):16343. doi: 10.1038/s41598-021-95835-5.
7
Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma.列线图构建与验证:预测肝癌患者癌症特异性死亡率和总死亡率。
Biomed Res Int. 2021 Mar 29;2021:1658403. doi: 10.1155/2021/1658403. eCollection 2021.
8
Laparoscopic liver resection for huge (≥10 cm) hepatocellular carcinoma: A coarsened exact-matched single-surgeon study.腹腔镜肝切除术治疗巨大(≥10厘米)肝细胞癌:一项粗匹配单术者研究
Surg Oncol. 2021 Jun;37:101569. doi: 10.1016/j.suronc.2021.101569. Epub 2021 Apr 3.
9
Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.中国肝细胞癌外科治疗的变化与挑战。
Biosci Trends. 2021 Jul 6;15(3):142-147. doi: 10.5582/bst.2021.01083. Epub 2021 Mar 14.
10
Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis.预测出现肺转移的肝细胞癌患者预后的列线图
Cancer Manag Res. 2021 Mar 1;13:2083-2094. doi: 10.2147/CMAR.S296020. eCollection 2021.